| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹15,262 | +1.75% | |
| 6 months | ₹30,000 | ₹32,558 | +8.53% | |
| 1 year | ₹60,000 | ₹68,588 | +14.31% | |
| 3 years | ₹1,80,000 | ₹2,21,842 | +23.25% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Repo | Unspecified | Repo | 22.66% |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | Equity | 10.58% |
| GLENMARK PHARMACEUTICALS LTD-29-Sep-2026 | Healthcare | Futures | 9.83% |
| Divi's Laboratories Ltd. 29.09.2026 | Healthcare | Futures | 9.46% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 9.30% |
| Pfizer Ltd | Healthcare | Equity | 8.83% |
| Glenmark Life Sciences Ltd | Healthcare | Equity | 8.08% |
| TORRENT PHARMACEUTICALS LTD.-29-Sep-2026 | Healthcare | Futures | 7.87% |
| Concord Biotech Ltd. | Healthcare | Equity | 7.03% |
| SMS Pharmaceuticals Ltd | Healthcare | Equity | 6.71% |
| Ipca Laboratories Ltd | Healthcare | Equity | 6.22% |
| Zydus Wellness Ltd | Consumer Staples | Equity | 5.64% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 5.18% |
| Strides Pharma Science Ltd | Healthcare | Equity | 2.45% |
| AUROBINDO PHARMA LTD.-29-Sep-2026 | Healthcare | Futures | 1.50% |
| GOVERNMENT OF INDIA 37477 091 DAYS TBILL 03SP26 FV RS 100 | Financial | Treasury Bills | 0.70% |
| GOVERNMENT OF INDIA 37490 091 DAYS TBILL 10SP26 FV RS 100 | Financial | Treasury Bills | 0.70% |
| 91 Days Tbill (MD 17/09/2026) | Financial | Treasury Bills | 0.70% |
| Reserve Bank of India 91-D | Financial | Treasury Bills | 0.70% |
| GOVERNMENT OF INDIA 37693 091 DAYS TBILL 22OT26 FV RS 100 | Financial | Treasury Bills | 0.70% |
| GOVERNMENT OF INDIA 37816 091 DAYS TBILL 05NV26 FV RS 100 | Financial | Treasury Bills | 0.69% |
| GOVERNMENT OF INDIA 37846 091 DAYS TBILL 19NV26 FV RS 100 | Financial | Treasury Bills | 0.69% |
| GOVERNMENT OF INDIA 37861 091 DAYS TBILL 27NV26 FV RS 100 | Financial | Treasury Bills | 0.69% |
| Sumitomo Chemical India Ltd | Materials | Equity | 0.31% |
| Net Payables | Unspecified | Net Payables | -27.21% |
| Name | 6M | 1Y | 3Y | All |
|---|---|---|---|---|
| Fund returns | +25.7% | +15.9% | +17.9% | +20.6% |
| Category average (Equity Sectoral) | +0.2% | -2.1% | +22.1% | -- |
| Rank (Equity Sectoral) | -- | 10 | 13 | -- |